68Ga-AAZTA-NI-093

N/A

Report date: 2025/11/21 17:16:27

NME

Base Information

Drug Name68Ga-AAZTA-NI-093

Drug Alias NameN/A

ClassificationRadiation-emitting products > Radioactive diagnostic agentSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Gallium > 68Ga +[4]

Mechanisms of ActionPositron-emission tomography enhancersProstate-Specific Membrane Antigen modulators

TargetsProstate-Specific Membrane Antigen

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesFirst Affiliated Hospital Of Fujian Medical University

China Registration ClassN/A

Develop Information

Active CompaniesFirst Affiliated Hospital Of Fujian Medical University

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A